Investigational Drug Information for AZD9833
✉ Email this page to a colleague
What is the drug development status for AZD9833?
AZD9833 is an investigational drug.
There have been 13 clinical trials for AZD9833.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 28th 2021.
The most common disease conditions in clinical trials are Breast Neoplasms, Liver Diseases, and Disease Progression. The leading clinical trial sponsors are AstraZeneca, Quotient Sciences, and Parexel.
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for AZD9833
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2021-01-28) |
| Vendors | 24 |
Recent Clinical Trials for AZD9833
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy | AstraZeneca | Phase 3 |
| Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects | AstraZeneca | Phase 1 |
| A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole | Parexel | Phase 1 |
Clinical Trial Summary for AZD9833
Top disease conditions for AZD9833
Top clinical trial sponsors for AZD9833
US Patents for AZD9833
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD9833 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD9833 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD9833
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD9833 | Argentina | AR109951 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | Australia | AU2017349797 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | Brazil | BR112019007393 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | Canada | CA3040040 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | Chile | CL2019001077 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | China | CN109843888 | 2036-10-24 | ⤷ Try a Trial |
| AZD9833 | China | CN114656464 | 2036-10-24 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
